BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 12378527)

  • 1. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.
    Kim TM; Yim SH; Shin SH; Xu HD; Jung YC; Park CK; Choi JY; Park WS; Kwon MS; Fiegler H; Carter NP; Rhyu MG; Chung YJ
    Int J Cancer; 2008 Dec; 123(12):2808-15. PubMed ID: 18803288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma.
    Wilkens L; Flemming P; Gebel M; Bleck J; Terkamp C; Wingen L; Kreipe H; Schlegelberger B
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1309-14. PubMed ID: 14745031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exonic variants undergoing allele-specific selection in cancers.
    Li Q; Zeng Y; Wang J; Fang H; Guo J; Yu L; Zhong T; Xu C; Freedman M; LaFramboise T
    BMC Med Genomics; 2021 May; 14(1):142. PubMed ID: 34059054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directional allelic imbalance profiling and visualization from multi-sample data with RECUR.
    Jakubek YA; San Lucas FA; Scheet P
    Bioinformatics; 2019 Jul; 35(13):2300-2302. PubMed ID: 30462146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of allelic imbalance with a statistical model for subtle genomic mosaicism.
    Xia R; Vattathil S; Scheet P
    PLoS Comput Biol; 2014 Aug; 10(8):e1003765. PubMed ID: 25166618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy.
    Nishida N; Nishimura T; Kaido T; Minaga K; Yamao K; Kamata K; Takenaka M; Ida H; Hagiwara S; Minami Y; Sakurai T; Watanabe T; Kudo M
    Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30274313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma.
    Nishida N; Kudo M; Nishimura T; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Inoue T; Minami Y; Ueshima K; Sakurai T; Yokomichi N; Nagasaka T; Goel A
    PLoS One; 2013; 8(9):e72312. PubMed ID: 24023736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.
    Chen L; Chan TH; Guan XY
    Acta Pharmacol Sin; 2010 Sep; 31(9):1165-71. PubMed ID: 20676120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.
    Peychal SE; Bilger A; Pitot HC; Drinkwater NR
    Carcinogenesis; 2009 May; 30(5):879-85. PubMed ID: 19255062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study.
    Longoni M; Orzan F; Stroppi M; Boari N; Mortini P; Riva P
    Neuro Oncol; 2008 Feb; 10(1):52-60. PubMed ID: 18094369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal instability and human hepatocarcinogenesis.
    Nishida N; Nishimura T; Ito T; Komeda T; Fukuda Y; Nakao K
    Histol Histopathol; 2003 Jul; 18(3):897-909. PubMed ID: 12792902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
    Lau SH; Guan XY
    Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.
    Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis.
    Nishimura T; Nishida N; Itoh T; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Genes Chromosomes Cancer; 2005 Jan; 42(1):34-43. PubMed ID: 15495198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.
    Nishimura T; Nishida N; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Cancer Genet Cytogenet; 2006 May; 167(1):57-65. PubMed ID: 16682288
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.